Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Total 13F shares
-
40,257,502
-
Share change
-
-965,052
-
Total reported value
-
$629,222,853
-
Put/Call ratio
-
1334%
-
Price per share
-
$15.63
-
Number of holders
-
82
-
Value change
-
-$16,748,703
-
Number of buys
-
48
-
Number of sells
-
27
Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2019
As of 31 Dec 2019,
Gossamer Bio, Inc. - Common Stock (GOSS) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,257,502 shares.
The largest 10 holders included
Omega Fund Management, LLC, HILLHOUSE CAPITAL ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, BOXER CAPITAL, LLC, ALLIANCEBERNSTEIN L.P., STATE STREET CORP, Artal Group S.A., and VICTORY CAPITAL MANAGEMENT INC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.